Objectives: In 2001, a randomized trial showed decreased mortality with early, goal-directed therapy in septic shock, a strategy later recommended by the Surviving Sepsis Campaign. Placement of a central venous catheter is necessary to administer goal-directed therapy. We sought to evaluate nationwide trends in: 1) central venous catheter utilization and 2) the association between early central venous catheter insertion and mortality in patients with septic shock. Design: We retrospectively analyzed the proportion of septic shock cases receiving an early (day of admission) central venous catheter and the odds of hospital mortality associated with receiving early central venous catheter from years 1998 to 2001 compared with 2002 to 2009. Setting: Non-federal acute care hospitalizations from the Nationwide Inpatient Sample, 1998-2009. Patients: A total of 203,481 (population estimate: 999,545) patients admitted through an emergency department with principal diagnosis of septicemia and secondary diagnosis of shock. Interventions: None.
reduction in nosocomial complications (e.g., venous thromboembolism, stress ulcer bleeding, ventilator-associated pneumonia [8] [9] [10] [11] ), or pseudo-improvements (e.g., changing International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] coding practices [2, 3] , or earlier discharge of patients to long-term care hospitals [3, 12] ).
Based on the results of a randomized controlled trial by Rivers et al (13) , the Surviving Sepsis Campaign Guidelines recommend early (i.e., within 6 hr) resuscitation in severe sepsis and septic shock. Because measurement of central venous pressure (CVP) and central venous oxygen saturation requires insertion of a central venous catheter (CVC), guideline-recommended, early goal-directed therapy cannot be implemented accurately without a CVC. Thus, study of the CVC in septic shock presents a unique opportunity to evaluate the evolution of utilization patterns and patient outcomes associated with a medical intervention before and after release of supporting evidence and guidelines.
Although Rivers et al demonstrated lower mortality with use of early goal-directed therapy guided by measurements from a CVC, how widely CVCs are used and outcomes associated with CVC use in typical practice in the United States remain unknown. We evaluated nationwide trends in CVC placement and compared mortality associated with early placement of a CVC for patients with septic shock in the 4 years before and 7 years after the publication of the trial by Rivers et al. We hypothesized that early insertion of a CVC in septic shock has increased since publication of the Surviving Sepsis Campaign. Furthermore, we hypothesized that in-hospital mortality associated with early placement of a CVC in septic shock has decreased after evidence-based therapeutic goals based on CVC measurements became widely available in 2001 (13) .
METHODS

Data Source
We examined hospitalizations from adults (age ≥18 yr) using years 1998 through 2009 discharge data from the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality (14) . The NIS is an approximately 20% stratified probability sample of all non-federal acute care hospitals and contains de-identified clinical and resource use information from approximately five to eight million hospital discharges yearly. NIS sampling strata are based on five hospital characteristics: ownership/control, teaching status, urban/rural location, U.S. region, and bed size. The 1998 NIS contained data from about 600 hospitals in 22 states and the 2009 NIS included data from approximately 1000 hospitals in 44 states. NIS elements include demographics, admission and discharge status, length of stay, up to 15 ICD-9-CM diagnosis and procedure codes (increased to 25 diagnosis codes in 2009), and hospital characteristics. Study procedures were approved by the Boston University Medical Campus Institutional Review Board.
Septic Shock Definition
Inclusion criteria for the trial of early goal-directed therapy (13) upon which Surviving Sepsis Campaign Guidelines were based included patients admitted through the emergency department with suspected severe sepsis or septic shock characterized by the systemic inflammatory response syndrome (15) [1] [2] [3] ). ICD-9-CM codes for sepsis, severe sepsis, and septic shock introduced in 2002 and 2003 require additional codes describing the infection, and in NIS data greater than 99% of cases with a code of 995.91, 995.92, or 785.52 also had a 038 code. Analysis of California State Inpatient data that include a "present on admission" modifier to diagnosis codes demonstrates that the sepsis diagnosis was coded as "present on admission" in 99% of patients with a principal diagnosis of sepsis or septicemia according to our algorithm.
CVC Definition and ICD-9-CM Validation
CVC placement was identified by ICD-9-CM procedure code 38.93. The resolution of procedure timing within the NIS is 1 day, thus "early" CVC placement was defined by placement of the CVC on the day of admission (day 0). "Late" CVCs were defined as those placed after the day of admission. We validated the CVC ICD-9-CM 38.93 code by retrospective chart review of 92 patients admitted to Boston Medical Center with septic shock ICD-9-CM codes in year 2009 and found 61% (95% confidence interval [CI] 50% to 72%) sensitivity and 92% (95% CI 61% to 100%) specificity. Prior validation of ICD-9-CM 38.93 during 1996-1997 showed 40% sensitivity and 99% specificity (20) .
Covariates
Demographic data collected in the NIS included age, sex, race, and ethnicity (coded as white, black, Hispanic, or others). Hospital characteristics included U.S. Census regions, teaching status, urban or rural location, and bed size (14) . We selected comorbid conditions through enhanced Charlson and Elixhauser ICD-9-CM codes (21) for heart failure, myocardial infarction, obesity, diabetes mellitus, chronic obstructive pulmonary disease, dementia, human immunodeficiency virus infection, paralysis, chronic liver disease, chronic kidney disease, and metastatic or hematologic malignancy. Acute factors were assessed through ICD-9-CM codes for number and type of acute organ dysfunction diagnoses (16, 22) , electrolyte abnormalities, critical care procedures (arterial catheterization, pulmonary artery catheterization, dialysis, mechanical ventilation), infectious pathogen type (Gram-positive vs. Gram-negative bacteria vs. fungal vs. none reported), infection source, and hospital strata characteristics. We estimated temporal trends in severity of illness through changes in the number of comorbid conditions, acute organ failures, and www.ccmjournal.org June 2013 • Volume 41 • Number 6 use of mechanical ventilation or dialysis. ICD-9-CM coding strategies are shown in Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/CCM/A608); we restricted analyses to the first 15 ICD-9-CM diagnoses to decrease bias from the increasing number of available coding positions on the discharge record during the study period.
Statistical Analyses
The primary outcome measure was the proportion of septic shock discharges receiving an early CVC each year. We derived national estimates from the NIS using hospital weights with SAS version 9.1.3 (SAS, Cary, NC) surveyfreq, surveymeans, and surveylogistic procedures. We performed multivariable logistic regression models with forward stepwise selection to determine factors associated with early CVC insertion during septic shock and used survey-weighted logistic regression to calculate effect estimates and standard errors for factors identified in conventional stepwise regression analysis. Annual percent change (APC) in placement of CVC, pulmonary artery, and peripheral arterial catheters was calculated with Joinpoint version 3.5.2 (Statistical Research and Applications Branch, National Cancer Institute, Bethesda, MD). To determine whether the association between CVC status and mortality was modified by year, we included a CVC status by year interaction term. Because of immortal time bias (23) associated with late CVC insertion, we excluded patients with late or unknown CVC timing from outcome analyses. We used the glimmix procedure to perform multivariable-adjusted logistic regression in a single model to calculate odds ratios (ORs) each year for hospital mortality associated with early CVC as compared with no CVC. Primary outcome models were adjusted for patient demographics, comorbid conditions, acute organ failures, procedures, infection site, pathogen, and hospital characteristics (Supplemental Table 2 , Supplemental Digital Content 1, http:// links.lww.com/CCM/A608). Patients with missing data (0.5% of cases) were excluded from our analyses. Because acute organ failures may occur after CVC placement and lie on the causal pathway to mortality, we analyzed secondary models including only demographics, comorbid conditions, and hospital characteristics. Finally, we compared early CVC-associated mortality prior to (1998) (1999) (2000) (2001) and after (2002-2009) publication of the Rivers et al study that demonstrated benefit to early, goaldirected therapy in severe sepsis and septic shock. A two-sided alpha level of 0.05 was selected for statistical significance.
Sensitivity Analyses
Because patients receiving mechanical ventilation may receive a CVC for reasons other than resuscitation (e.g., administration of continuous sedative medications) and mechanical ventilation is a major prognostic determinant in severe sepsis (3), we performed a sensitivity analysis stratifying by use of mechanical ventilation (ICD-9-CM 96.7). To eliminate confounding from the changing number of states contributing to NIS over time, we performed a sensitivity analysis including only the 20 states that contributed data each year from 1998 to 2009 (California, Colorado, Florida, Iowa, Illinois, Massachusetts, New Jersey, Washington, Wisconsin, Connecticut, Kansas, Maryland, New York, Oregon, South Carolina, Missouri, Tennessee, Georgia, Hawaii, and Utah). To examine whether trends in CVC insertion rates and associated outcomes were general trends associated with vascular access procedures in patients with septic shock, or are more specific to the CVC, we analyzed placement and outcome trends associated with the arterial catheter (ICD-9-CM 38.91) and pulmonary artery catheter (ICD-9-CM 89.63, 89.64, 89.66, 89.67, 89.68 [24] ). Finally, to address whether increasing early discharge of patients to other hospitals might confound the association of early CVC placement and hospital mortality, we performed an analysis that excluded patients discharged to another facility (e.g., longterm or acute care hospitals).
RESULTS
Septic Shock Epidemiology, 1998-2009
We identified 203,481 hospitalizations with septic shock representing approximately one million weighted discharges from years 1998 to 2009 (Supplemental Fig. 1 Table 2 , Supplemental Digital Content 1, http://links.lww.com/CCM/A608), age-adjusted hospital mortality associated with septic shock hospitalization declined from 40.4% in 1998 to 31.4% in 2009 ( Fig. 1) . Joinpoint regression models identified that septic shock-associated hospital mortality decreased more rapidly after 2004 (APC, -4% [95% CI -5% to -3%]) as compared with prior to 2004 (AP,: -1.7% [95% CI, -2.9% to -0.3%]), p = 0.01. Table 1 . Patients who received an early CVC were more likely to be younger, female, black race, with a greater number of acute organ failures, and to have Medicare as payer. Patients discharged from large, urban, or teaching hospitals were also more likely to receive an early CVC. Patients with metastatic malignancy, dementia, chronic kidney disease, chronic liver disease, and hospitalized in the Midwest region were less likely to receive an early CVC.
Trends in Catheter Placement
From 1998 to 2009, early CVC insertion increased from 5.7% (95% CI, 5.1% to 6.3%) to 19.2% (95% CI, 18.7% to 19.5%) of patients with septic shock (Fig. 2) . Joinpoint regression 
Trends in Catheter-Associated Mortality
Receipt of early CVC was associated with a greater annual decline (APC, -4.2%, 95% CI -3.2, -4.2%) in age-adjusted septic shock mortality than no CVC (APC -2.9 [95% CI -2.3, -3.5%]), p = 0.016 ( Fig. 3) . Hospital mortality associated with early use of a CVC significantly decreased from a multivariable-adjusted OR of 1.27 (95% CI, 0.96-1.68) in 1998 to an OR of 0.88 (95% CI 0.83-0.95) in 2009 (p < 0.001) (Fig. 4A) 
DISCUSSION
We performed a population-based assessment of CVC utilization trends and outcomes in patients with septic shock. A CVC facilitates delivery of medications and allows for measurement of CVP and central venous oxygen saturation. However, as shown by prior studies that evaluated the pulmonary artery catheter in the critically ill (25) (26) (27) , interventions that yield clinical data without evidence-based instructions for how to act upon the data may not improve outcomes. Similar to the lack of outcome benefit associated with use of the pulmonary artery catheter, we found that use of a CVC during early septic shock was not associated with improved adjusted mortality prior to publication of the study by Rivers et al (OR, 1.29). However, after publication of the study by Rivers et al and release of the Surviving Sepsis Campaign guidelines, early CVC placement increased three-fold and early CVC-associated adjusted mortality declined (OR, 0.87).
We are not aware of other studies that have investigated population-based trends in septic shock CVC practice patterns. However, studies by Levy et al (4) found that 71% of respondents stated they would place a CVC in a patient with septic shock and 44% would aim for CVP goal of 8 to 12 mm Hg (28) . However, survey responses variably correlate with actual physician practice (29) (30) (31) . These results highlight a limitation of our study: Whereas early CVC placement is necessary to attempt early goal-directed therapy, placement of a CVC is not sufficient to ensure that it is delivered effectively.
We identified several factors associated with early CVC placement in patients with septic shock. Patients receiving an early CVC were younger and more likely to have a greater number of acute organ failures. However, certain comorbid conditions, such as dementia, metastatic cancer, and chronic liver, kidney, or lung diseases, were associated with a lower likelihood of receiving an early CVC. Many factors might explain these findings, including decisions to limit the invasiveness of care, or pre-existing central venous access (e.g., hemodialysis catheters or tunneled catheters for chemotherapy) mitigating the need for a new CVC. Acute hematological or hepatic failures were associated with a decreased likelihood of receiving an early CVC; these conditions are often associated with coagulopathy that may complicate timely catheter insertion. Our findings of differences in CVC utilization patterns according to hospital size, teaching status, and region were similar to those of prior studies in heart failure (32) and myocardial infarction (33, 34) demonstrating that larger, academic hospitals (35) may be more apt to adopt guidelines or quality improvement initiatives (36) .
Our study has limitations. Increasing utilization of early CVC in septic shock may potentially be explained by changing sensitivity of ICD-9-CM codes over time; however, ICD-9-CM validation in 2009 did not show substantially different sensitivity from prior validation of CVC claims in 1996 and 1997 (20) . Furthermore, if the increase in CVC use over time merely reflected an increased tendency to code vascular access procedures, we would expect to observe similar increases in coding of pulmonary artery catheterization or peripheral arterial catheterization; no such trend was observed. Our data likely imperfectly estimate the true placement rates of early CVCs due to low sensitivity for the ICD-9-CM code, resolution of the procedure codes to the level of hospital day (making it impossible to ascertain whether CVC were placed within 6 hr of presentation), and the possibility that septic shock may have developed later during a hospitalization. We suspect that any misclassification of CVC status would not be associated with inpatient mortality over time, and thus is likely non-differential misclassification of CVC exposure that would bias our estimates toward the null. We could not ascertain the site of CVC placement (i.e., femoral, subclavian, internal jugular vein, peripherally inserted central catheter), which may affect the accuracy of CVP or central venous oxygen saturation measurements.
Moreover, associations between emerging clinical evidence and practice guidelines, increasing insertion of early CVCs, and improved septic shock mortality cannot be assumed to be causal in an observational study using administrative data. We cannot exclude residual confounding from unmeasured covariates unavailable in NIS administrative claims data, such as information on vital signs, laboratory results, or timing of diagnoses. Additionally, we cannot exclude that rising rates of early CVC placement correlated with an increased quality of care in general, including concurrent implementation of other elements of the Surviving Sepsis bundle (e.g., early antibiotic administration) that could not be measured with NIS data. In addition, results may potentially be biased by temporal changes in coding practices (37) , as the validity of septic shock coding in particular has not been fully established. However, if changes in coding practices were the explanation for our findings, then we would expect to find that CVCs were placed in patients with decreasing illness severity over time. In contrast, we found that patients receiving early CVC had evidence of increasing illness severity over time (more comorbid conditions, mechanical ventilation, dialysis, and greater number of acute organ failures) that would likely bias toward increasing odds of death associated with CVC placement. Furthermore, similar outcome trends were not identified for other procedures for which evidence-based protocols do not currently exist (peripheral arterial catheters and pulmonary artery catheters). Notably, Joinpoint regression analyses identified a significant change in septic shock mortality trends only after the 2004 publication of the Surviving Sepsis Campaign, and the decline in septic shock mortality over time was greater in patients receiving early CVC compared with no CVC. Our results cannot be explained by the availability of new sepsis ICD-9-CM codes after 2002, as these codes only modify the existing 038 codes and do not increase sensitivity for ascertaining sepsis cases above that of 038 codes alone. Other studies have suggested that improvements in severe sepsis mortality may be the result of early patient discharge to other facilities (3, 12) , but our results were not altered by excluding patients discharged to other facilities. Thus, correlation between early CVC insertion and changing patient discharge practices is unlikely to explain our findings.
CONCLUSIONS
Severe sepsis-associated hospital mortality has declined during the past decade. We investigated trends in septic shock mortality associated with early CVC placement, a procedure necessary to implement early goal-directed therapy recommended by the Surviving Sepsis Campaign. In patients likely to have septic shock, early CVC utilization increased and hospital mortality associated with early CVC placement improved during the time period after evidence-based guidelines for use of a CVC became widely available. We speculate that U.S. healthcare providers have increasingly begun to implement evidenced-based recommendations regarding use of the CVC in the care of patients with septic shock, a behavior change associated with improved outcomes. In order to focus quality improvement efforts on strategies with high clinical impact, future studies should seek to investigate additional factors contributing to the decline in sepsis-associated mortality in chart-verifiable data sources.
